accountfor doing this each year, Peacock said, "When you think about the fight that thousands of folks with multiple...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.
Multiple Sclerosis is part of Business Exchange, suggested by
Steve McCarthy.
This topic contains
967 news
and
242 blog
items.
Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from
like-minded professionals.
News
Please add new articles to this topic
Study shows oral drug laquinimod is safe and effective if($defined(usm))} (WebMD) The experimental oral multiple...
results for their two-year Phase III Allegro clinical trial of Laquinimod, an oral treatment of relapsing forms of...
commonly used for smoking marijuana.Williams, who says he legally uses marijuana to treat chronic pain caused by...
Teva Pharmaceutical Industries Ltd's (TEVA.TA) experimental multiple sclerosis pill laquinimod reduced the disease's...
Inc.| AA Teva Pharmaceutical Industries Ltd.| TEVA Durect Corporation| DRRX Teva Pharmaceutical's (TEVA) experimental...
waste management.��� Dr. Lorber discussed a case study that showed consistent patient adherence can result in savings.
currently sells Avonex and co-markets Tysabri with Elan (NYSE: ELN There's plenty of competition from other injectable...
100% on Wednesday. Biogen Idec (Nasdaq: BIIB) reported positive results from a late stage clinical trial of its...
to think again. Recent studies suggest these old virus shards may play a role in Hodgkin's lymphoma, multiple...
Extract not available.
saying it had a long-time relationship with Goldman. Positive Results: In a late-stage trial, Biogen Idec���s oral...
Biogen Idec Inc's (BIIB.O) experimental multiple sclerosis drug met the main goal in the first of two...
Biogen Idec Inc's (BIIB.O) experimental multiple sclerosis drug met the main goal in the first of two important...
[P04.193] Insights from the Coptimize Study: Characteristics of Relapsing Remitting Multiple Sclerosis (RRMS) Patients...
TheStreet) --Biogen Idec(BIIB) said Monday that treatment with an experimental pill reduced the proportion of patients...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced data analyses showing that people with multiple sclerosis (MS)...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style.
Biogen Idec Inc's (BIIB.O) experimental multiple sclerosis drug met the main goal in the first of two important...
percent, to $78.55, and was the top percentage gainer on the Nasdaq 100 after the companys experimental multiple...
Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of...
potential milestones and a royalty on sales. Novartis has won FDA and European approval for its disease modifying...
drug, which has been approved in some European countries and Canada as a treatment for spasticity due to multiple...
for the biggest increase in the Standard & Poor���s 500 Index. The world���s largest maker of multiple sclerosis...
the Middle East, apart from Israel. The Salisbury-based firm, which has pioneered pain relief research for sufferers of...
Top Sources: Multiple Sclerosis
- St. Petersburg Times
- Reuters
- Chicago Tribune
- MarketWatch
- Mail Online UK
- BBC
- Boston Globe
- Philadelphia Inquirer
- BusinessWeek
- Wall Street Journal Online
Post a Job
Jobs in this Topic
RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center
Rush University Medical Center
|
Chicago, IL
Posted: May 14
Client in West Virginia Seeking Multiple Neurologist
Alliance Recruiting Resources
|
West Virginia
Posted: Jun 18